iiinova — where your digital self keeps evolving

Michael Paley, M.D., Ph.D.

@drmapaley.bsky.social

400 followers 51 following 8 posts

Ocular Rheumatologist | @WashUMedRheum | T cell biology and scRNAseq/TCRseq | full of dry and nerdy humor Paleylab.com

Posts Replies Media

Michael Paley, M.D., Ph.D. @drmapaley.bsky.social · 29/09/2026

You can now view our abstract using this link and the summary images below: www.biorxiv.org/content/10.6... @obigriffith.bsky.social @malachigriffith.bsky.social @thehumanborch.bsky.social #Rheumsky #axSpA (1/4)

132

Michael Paley, M.D., Ph.D. @drmapaley.bsky.social · 28/02/2025

Thank you, @drkilianmd.bsky.social, for inviting me to speak at St. Louis University’s Rheumatology Grand Rounds this morning! It’s always great to see our neighbors to the East and talk shop! @washumedrheum.bsky.social #Rheumatology

071

Reposted by Michael Paley, M.D., Ph.D.

WashU Medicine Division of Rheumatology @washumedrheum.bsky.social · 06/02/2025

(2/2) podcast episode here: rheummadness.buzzsprout.com/1465681/epis... Next week @sambhawanabhandari.bsky.social will shoot her shot and show why "Shooting for Remission" should be this year's RheumMadness winner! @ariellastudies.bsky.social @alhkim.bsky.social @laceyfeigl.bsky.social

142

Reposted by Michael Paley, M.D., Ph.D.

WashU Medicine Division of Rheumatology @washumedrheum.bsky.social · 06/02/2025

We had so much fun recording this week's @rheummadness.bsky.social podcast episode to talk about our #RheumMadness scouting report on "Steroid Dose in Lupus Nephritis"! You can find our scouting report here: sites.duke.edu/rheummadness... and the first half of the "Full Court Care Champions" (1/2)

1135

Michael Paley, M.D., Ph.D. @drmapaley.bsky.social · 24/01/2025

I am very honored by the selection and grateful for all the support that has gotten me and my lab to this point.

030

Michael Paley, M.D., Ph.D. @drmapaley.bsky.social · 17/11/2024

I’ll be presenting at 3pm in Ballroom B (1755) on “Single Cell TCR Sequencing Suggests Potential Limitations of TRVB9-depleting Therapies in Axial Spondyloarthritis”. Would love to chat about our work if you stop by! @washumedrheum.bsky.social #ACR24

1103